Evidence map›Paper›PMID 35038631›Full record

ArticlePublic health2022

Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies.

P Ferrara, D Ponticelli, F Agüero, G Caci, A Vitale, M Borrelli, B Schiavone, I C Antonazzo, L G Mantovani, V Tomaselli and 1 more

Open access · greenAbstract read
In one paragraph

Article in Public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. How does geographical diversity shape vaccine efficacy?Clinical and experimental vaccine research · 2024
    Review
  7. Article
  8. Article
  9. Vaccinomics and adversomics: key elements for a personalized vaccinology.Clinical and experimental vaccine research · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

P FerraraCenter for Public Health Research, University of Milan - Bicocca, Monza, Italy; IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy; Pineta Grande Hospital, Castel Volturno, Caserta, Italy. Electronic address: p_ferrara@alice.it.
D PonticelliPineta Grande Hospital, Castel Volturno, Caserta, Italy.
F AgüeroPreventive Medicine Department, University Hospital of Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Clinical Science Department, School of Medicine, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
G CaciUnit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
A VitalePineta Grande Hospital, Castel Volturno, Caserta, Italy.
M BorrelliPineta Grande Hospital, Castel Volturno, Caserta, Italy.
B SchiavonePineta Grande Hospital, Castel Volturno, Caserta, Italy.
I C AntonazzoCenter for Public Health Research, University of Milan - Bicocca, Monza, Italy.
L G MantovaniCenter for Public Health Research, University of Milan - Bicocca, Monza, Italy; IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy.
V TomaselliDepartment of Political and Social Sciences, University of Catania, Catania, Italy; Center of Excellence for the Acceleration of HArm Reduction (CoEHAR), University of Catania, Catania, Italy.
R PolosaCenter of Excellence for the Acceleration of HArm Reduction (CoEHAR), University of Catania, Catania, Italy; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Villa Pineta Hospital · ITMultiMedica · ITUniversity of Catania · ITBellvitge University Hospital · ESUniversity of Messina · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was to investigate the possible impact of smoking on the humoral response to the BNT162b2 mRNA COVID-19 vaccine (also known as the BioNTech-Pfizer COVID-19 vaccine). STUDY

designA longitudinal sero-epidemiological study was conducted in sample of Italian healthcare workers (HCWs).

methodsHCWs who were administered two doses of the BNT162b2 mRNA vaccine, 21 days apart, between December 2020 and January 2021, were invited to undergo multiple serology tests to identify SARS-CoV-2 S-RBD-specific immunoglobulin G (IgG) antibodies. Participants also responded to questions about their smoking status (i.e. current smokers vs non-smokers) in a survey.

resultsSixty days after the completion of the vaccination cycle, serological analyses showed a difference in vaccine-induced IgG titre between current smokers and non-smokers, with median antibody titres of 211.80 AU/mL (interquartile range [IQR] 149.80-465.50) and 487.50 AU/mL (IQR 308.45-791.65) [P-value = 0.002], respectively. This significant difference in vaccine-induced IgG titres between current smokers and non-smokers remained after adjusting for age, sex, and previous infection with SARS-CoV-2.

conclusionsThis study observed that vaccine-induced antibody titres decrease faster among current smokers than non-smokers. Further research to investigate the impact of smoking on the immunological response to COVID-19 and non-COVID-19 vaccines is required.

Indexed as

COVID-19COVID-19 VaccinesAntibodies, ViralBNT162 VaccineHumansmRNA VaccinesSARS-CoV-2SmokingVaccines, SyntheticAntibodies, ViralBNT162 VaccineCOVID-19 VaccinesmRNA VaccinesVaccines, SyntheticBNT162b2 vaccineCOVID-19SARS-CoV-2SmokingVaccine response

Identifiers

PMID35038631
PMCPMC8786634
OpenAlexW4206666297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.